OptimizeRx Corp
OPRX· Nasdaq
OPRXOptimizeRx Corp
Filed Mar 30, 2012 · 10-K · 90 days after period end · 0001255294-12-000205
derived · Computed from the longer spans the company filed.
| Metric | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|
| Revenue | $325.91K | — |
| Net Income | -$93.14K | -$368.58K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
OptimizeRx Corp · CIK 1448431 · Engraved from SEC EDGAR
ended Dec 31, 2011 · filed Mar 30, 2012 · 90 d after period end
